论文部分内容阅读
为探讨改善微循环疗法对肺结核治疗的影响,我们对初治肺结核患者,在化疗同时加用改善微循环的药物,收到较好的辅助治疗作用。现报告如下。 1 对象与方法 1.1 对象与分组共70例,均为符合1978年全国结核病会议诊断标准,住院治疗在4个月以上;年龄18～59岁,无其它脏器合并症,甲皱微循环—肺血流图—血液流变学检测异常的初治病例。随机分为:①治疗组40例,其中男35例,女5例,平均年龄41.3岁;肺结核Ⅱ型2例均为两肺广泛病变者,Ⅲ型33例中病变达1个肺野15例,2个肺野10例,3个肺野以上8例,
In order to explore the impact of improving microcirculation therapy on tuberculosis treatment, we have received better adjuvant therapy for newly diagnosed tuberculosis patients while adding drugs for improving microcirculation in chemotherapy. The report is as follows. 1 Subjects and Methods 1.1 objects and sub-groups of 70 cases, all in line with the diagnostic criteria of the National Tuberculosis Conference in 1978, hospitalization in 4 months or more; aged 18 to 59 years old, no other complications of organ, microcephaly - pulmonary Blood flow diagram - initial treatment of abnormal blood rheology. Randomly divided into: ① treatment group of 40 patients, 35 males and 5 females, mean age 41.3 years; tuberculosis Ⅱ type 2 cases were extensive lesions of both lungs, 33 cases of type Ⅲ disease in 1 lung field in 15 cases , 2 lung field in 10 cases, 3 lung field above 8 cases,